Le Lézard
Classified in: Health

TOMI Environmental Solutions, Inc. to Hold Third Quarter 2017 Financial Results Conference Call on November 16, 2017

TOMI Environmental Solutions, Inc. to Hold Third Quarter 2017 Financial Results Conference Call on November 16, 2017

BEVERLY HILLS, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (?TOMI?) (OTCQX:TOMZ), a global decontamination and infection prevention company that specializes in disinfection/decontamination sales and services, including the manufacturing, sale and licensing of its SteraMisttm, a hydrogen peroxide-based mist/fog that is registered with the U.S. Environmental Protection Agency (?EPA?) for use as a hospital healthcare disinfectant, announced it will hold its third quarter 2017 financial results conference call on Thursday, November 16th at 1:30 p.m. PT, 4:30 p.m. ET.

To listen to the call, please dial 1-888-339-0752 or 1-412-902-4193. To listen to the webcast or view the press release, please visit the Investor Relations section of the TOMI website at: http://www.tomimist.com/us/investors/. The replay can be accessed for one week starting at 6:30 p.m. ET the day of the call by dialing 1-877-344-7529 or 1-412-317-0088, replay access code 10111508. A replay of the webcast will be available for at least 90 days on the company's website, starting approximately one hour after the completion of the call.

About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier Binary Ionization Technology® (BITtm) platform, which was invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense. BITtm uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical (OH ion), represented by the TOMItm SteraMisttm brand of products, which produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI's products are designed to service a broad spectrum of commercial structures including but not limited to hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities (when not in operation), military barracks, police and fire departments, and athletic facilities. TOMI's products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing of The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.

For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute ?forward-looking statements? as defined in the Private Securities Litigation Reform Act of 1995 (the ?Reform Act?). Forward-looking statements are identified by such words and phrases as ?we expect,? ?expected to,? ?estimates,? ?estimated,? ?current outlook,? ?we look forward to,? ?would equate to,? ?projects,? ?projections,? ?projected to be,? ?anticipates,? ?anticipated,? ?we believe,? ?could be,? and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.


Juliana deRosa
Executive Administrator

These press releases may also interest you

at 10:00
US demand for medical services is forecast to reach $3.1 trillion in 2021, according to Medical Services: United States, a report recently released by Freedonia Focus Reports. Providers of medical services are expected to benefit from continued...

at 10:00
AgileTrailblazers, a Virginia-based management consultancy firm, has sponsored the New Jersey Hospital Association (NJHA) 99th Annual Meeting. The meeting will take place Friday, Jan. 19, at the Hyatt Regency Princeton in Princeton, New Jersey. NJHA...

at 10:00
A registry that tracks the quality of medical care provided to patients receiving cancer treatment launched this month as part of a collaboration between the American Society of Clinical Oncology (ASCO) and the American Society for Radiation Oncology...

at 10:00
Recognizing that tomorrow's innovation relies on exposing the next generation to why science matters today, New England Biolabs® (NEB®) has become the primary sponsor of the LabCentral Learning Lab. LabCentral, Greater Boston's premier co-working...

at 10:00
The Interventional Initiative (Oakland, CA) and Evolve Media Production (San Francisco, CA, and New York, NY) announce distribution of Episode 3: HYSTERical of Without a Scalpel on Amazon Video On Demand. Episode 3: ...

at 10:00
Sherwin Edwards, Founder, President and CEO of Vap Select will join a cross section of experts who will discuss the merits of vaping as an alternative to cigarette smoke, to understand if vaping is really an option as a harm-reduction and life-saving...

News published on 10 november 2017 at 19:03 and distributed by: